Should You Invest in Artivion (AORT)? [Yahoo! Finance]
Artivion, Inc. (AORT)
Company Research
Source: Yahoo! Finance
A copy of the letter can be downloaded here . The equities market in 2024 saw mixed results in the second quarter. Small-cap indices generally posted negative results, whereas large-cap indices posted favorable results. The strategy returned (3.32)% net of fees in the quarter, compared to a (2.91)% return for the Russell 2000 Growth Index. In addition, please check the fund's top five holdings to know its best picks in 2024. NCG Small Cap Strategy highlighted stocks like Artivion, Inc. (NYSE: AORT ), in the second quarter 2024 investor letter. Artivion, Inc. (NYSE:AORT) is a global manufacturer and distributor of medical devices and implantable human tissues. The one-month return of Artivion, Inc. (NYSE:AORT) was 0.37%, and its shares gained 58.75% of their value over the last 52 weeks. On August 29, 2024, Artivion, Inc. (NYSE:AORT) stock closed at $26.86 per share with a market capitalization of $1.125 billion. NCG Small Cap Strategy stated the following regarding Artivion, Inc.
Show less
Read more
Impact Snapshot
Event Time:
AORT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AORT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AORT alerts
High impacting Artivion, Inc. news events
Weekly update
A roundup of the hottest topics
AORT
News
- Artivion, Inc. (NYSE: AORT) had its price target raised by analysts at Stifel Nicolaus from $28.00 to $30.00. They now have a "buy" rating on the stock.MarketBeat
- Is Now An Opportune Moment To Examine Artivion, Inc. (NYSE:AORT)? [Yahoo! Finance]Yahoo! Finance
- Organ and Tissue Transplantation Strategic Research Report 2023-2030: Rising Focus on Immunosuppressive Therapies Strengthens Business Case for Post-Transplant Care [Yahoo! Finance]Yahoo! Finance
- A Look At The Intrinsic Value Of Artivion, Inc. (NYSE:AORT) [Yahoo! Finance]Yahoo! Finance
- Artivion, Inc. (AORT) Q2 2024 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
AORT
Earnings
- 8/8/24 - Beat
AORT
Sec Filings
- 8/27/24 - Form 4
- 8/26/24 - Form 144
- 8/19/24 - Form 4
- AORT's page on the SEC website